Rapamycin (Sirolimus): Uses, Mechanism & Research
Rapamycin (sirolimus) is an immunosuppressive drug used to prevent organ transplant rejection and is being studied as a potential anti-aging compound.
Things worth knowing about "Rapamycin"
Rapamycin (sirolimus) is an immunosuppressive drug used to prevent organ transplant rejection and is being studied as a potential anti-aging compound.
What is Rapamycin?
Rapamycin, also known by its generic name sirolimus, is a naturally occurring macrolide compound with potent immunosuppressive and antiproliferative properties. It was first isolated in the 1970s from the soil bacterium Streptomyces hygroscopicus, discovered on Easter Island (Rapa Nui) – hence the name rapamycin. Today, it is best known as an mTOR inhibitor and has a broad range of clinical and investigational applications.
Mechanism of Action
Rapamycin works by inhibiting the mechanistic target of rapamycin complex 1 (mTORC1), a central kinase that regulates cell growth, proliferation, metabolism, and autophagy (the process by which cells break down and recycle damaged components).
- Rapamycin binds to the intracellular protein FKBP12.
- The resulting complex binds to mTORC1, inhibiting its activity.
- This leads to reduced T-cell proliferation and a dampened immune response.
- Simultaneously, autophagy is enhanced, promoting cellular housekeeping and renewal.
Medical Uses
Organ Transplantation
The primary approved clinical use of rapamycin is the prevention of kidney transplant rejection. It is used in combination with other immunosuppressive agents to prevent the recipient's immune system from attacking the donor organ.
Oncology
Rapamycin analogues (known as rapalogs, such as everolimus and temsirolimus) are approved for treatment of several cancers, including:
- Renal cell carcinoma
- Hormone receptor-positive, HER2-negative breast cancer
- Pancreatic neuroendocrine tumors
- Mantle cell lymphoma
Rare Diseases
Everolimus, a rapamycin analogue, is used in tuberous sclerosis complex and lymphangioleiomyomatosis (LAM), conditions in which the mTOR pathway is constitutively overactivated due to genetic mutations.
Rapamycin in Anti-Aging Research
Rapamycin has attracted significant scientific interest as a potential longevity-promoting compound. Animal studies, particularly in mice, have demonstrated that rapamycin can extend lifespan even when administered in middle age. The proposed mechanisms include:
- Enhanced autophagy and clearance of damaged cellular components
- Slowing of cellular senescence (biological aging of cells)
- Reduction of chronic low-grade inflammation (inflammaging)
- Improvement of mitochondrial function
Human clinical trials examining anti-aging effects of rapamycin are still in early stages. The PEARL trial is currently investigating potential health benefits of low-dose rapamycin in healthy older adults.
Dosage and Administration
In clinical transplantation settings, rapamycin is administered orally as a tablet or oral solution. Dosing is individualized and closely monitored through therapeutic drug monitoring (TDM) using blood trough level measurements. A typical maintenance dose for kidney transplant recipients ranges from 2 to 5 mg per day, though the exact dose is always determined by the treating physician.
Side Effects
Rapamycin can cause a range of side effects, particularly with long-term or high-dose use:
- Increased risk of infections due to immunosuppression
- Dyslipidemia (elevated triglycerides and cholesterol)
- Impaired wound healing
- Increased risk of certain cancers (e.g., non-melanoma skin cancer)
- Non-infectious pneumonitis
- Renal function impairment
- Oral ulcers (stomatitis)
In non-approved uses such as self-experimentation for longevity purposes, rapamycin should only ever be used under close medical supervision.
Drug Interactions
Rapamycin is primarily metabolized by the hepatic enzyme CYP3A4. Therefore, numerous drugs and foods can significantly alter its blood concentration:
- Increased levels: Azole antifungals (e.g., ketoconazole), macrolide antibiotics (e.g., clarithromycin), grapefruit juice
- Decreased levels: Rifampicin, St. John's Wort, certain antiepileptic drugs
References
- Saxton, R.A. & Sabatini, D.M. (2017): mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6), 960–976. doi:10.1016/j.cell.2017.02.004
- Arriola Apelo, S.I. & Lamming, D.W. (2016): Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. The Journals of Gerontology, 71(7), 841–849.
- European Medicines Agency (EMA): Rapamune (sirolimus) – Summary of Product Characteristics. Last updated 2023. Available at: www.ema.europa.eu
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Rapamycin